bioMérieux
banner
biomerieux.com
bioMérieux
@biomerieux.com
We are global leader in in vitro diagnostics committed to improving public health worldwide. Since 1963, our innovative diagnostics solutions help healthcare professionals make confident decisions to enhance patient outcomes.
💡Key insights:

• Detects very low troponin for improved early AMI diagnosis.
• Enables near-patient testing, some using capillary blood.
• Lab-grade performance with faster turnaround (8–20 min).
• Simplifies maintenance and supports emergency workflows.

#MedSky #CardioSky
November 26, 2025 at 8:38 AM
Key results:

➡ Antibiotic prescribing was lower among patients with viral detections VS to those with no targets detected (6.5% vs 20.2%)

➡ ED length of stay dropped by over 2 hours

➡ 92% of patients reported high satisfaction

➡ 76% of clinicians felt confident in their decisions

#Medsky
November 12, 2025 at 2:56 PM
Congrats! 👏
October 29, 2025 at 8:08 AM